Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -22.55% | -43.10% | -0.15% | 21.50% | 9.59% |
| Gross Profit | 22.72% | 43.27% | 0.44% | -21.50% | -9.59% |
| SG&A Expenses | 10.80% | 13.88% | -78.26% | 28.05% | 97.98% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -11.19% | -22.13% | -15.80% | 24.25% | 29.25% |
| Operating Income | 11.30% | 22.24% | 16.02% | -24.25% | -29.25% |
| Income Before Tax | 13.46% | 70.09% | -2,271.64% | 37.21% | -31.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.46% | 70.09% | -2,271.64% | 37.21% | -31.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.46% | 70.09% | -2,271.64% | 37.21% | -31.51% |
| EBIT | 11.30% | 22.24% | 16.02% | -24.25% | -29.25% |
| EBITDA | 10.30% | 22.01% | 17.23% | -26.19% | -32.41% |
| EPS Basic | 27.53% | 90.33% | 21.36% | 89.04% | 76.95% |
| Normalized Basic EPS | 27.53% | 74.56% | -154.32% | 71.55% | 77.28% |
| EPS Diluted | 27.53% | 90.33% | 21.36% | 89.04% | 76.95% |
| Normalized Diluted EPS | 27.53% | 74.56% | -154.32% | 71.55% | 77.28% |
| Average Basic Shares Outstanding | 19.41% | 209.32% | 487.42% | 473.03% | 470.46% |
| Average Diluted Shares Outstanding | 19.41% | 209.32% | 487.42% | 473.03% | 470.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |